ALKBH5 and systemic lupus erythematosus: Similar to the screening set, the results demonstrated that the expression of METTL14, ALKBH5, and YTHDF2 was all significantly decreased in PBMCs from SLE patients compared with HC (all p < .0001) (Figure 2a–c).